Page 4 - Davida Ricks News Today

After regulators approved Zepbound to help treat obesity, drugmaker Eli Lilly launched a website making it easier to access the drug.

After regulators approved Zepbound to help treat obesity, drugmaker Eli Lilly launched a website making it easier to access the drug.

Drugmaker Eli Lilly has launched a digital healthcare platform for obesity, migraine and diabetes patients, offering things like access to healthcare providers.

Insulin price caps from Eli Lilly, Novo Nordisk and Sanofi take effect this month.

The truth is that the best ideas are often psychotic, obscene, and unoriginal.

Lilly cuts its guidance for full-year earnings to a range of $6.50 to $6.70 a share, having raised its outlook in August to a range of $9.70 to $9.90.

Strong sales growth driven by Mounjaro, Verzenio, and Jardiance

In addition to Eli Lilly, Novo Nordisk and Moderna, Regeneron also produced its latest quarterly earnings report Thursday morning.

This week, the U.S. Department of Commerce’s Economic Development Administration announced that Indiana-based Heartland BioWorks, a consortium led by the Applied Research Institute, has been designated as a Regional Technology

Succeeding Mike Mason on January 1, 2024 will be company veteran Patrik Jonsson, who currently serves as EVP and president of Lilly USA.